Results 121 to 130 of about 21,457 (218)

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.

open access: yes, 2014
Patients with essential thrombocythemia may carry JAK2 (V617F), an MPL substitution, or a calreticulin gene (CALR) mutation. We studied biologic and clinical features of essential thrombocythemia according to JAK2 or CALR mutation status and in relation ...
Pietra, D   +19 more
core   +1 more source

Pseudo-acquired vWD in essential thrombocythemia: the role of platelets

open access: yes, 2014
Essential Thrombocythemia affects von Willebrand ...
Lancellotti, Stefano   +4 more
core  

Essential thrombocythemia as underlying cause of malabsorption syndrome.

open access: yes, 2010
Essential thrombocythemia as underlying cause of malabsorption ...
Teofili, Luciana   +6 more
core  

Lipid-lowering drugs and essential hemorrhagic thrombocythemia's risk: A drug-target Mendelian randomization study. [PDF]

open access: yesMedicine (Baltimore)
Zhang P   +8 more
europepmc   +1 more source

A novel t(2;17) in transformation of essential thrombocythemia to acute myelocytic leukemia

open access: yes, 2004
A transformation of essential thrombocythemia to acute myelocytic leukemia (AML), myelodysplastic syndrome, or agnogenic myelocytic metaplasia is a relatively rare event.
Jankovic, Gradimir M   +6 more
core  

<i>Erratum</i> to: "Multilevel defects in the hematopoietic niche in essential thrombocythemia". [PDF]

open access: yesHaematologica
Sun T   +16 more
europepmc   +1 more source

Essential Thrombocythemia-Associated Distal Radial Pseudoaneurysm Treated With Thrombin Injection. [PDF]

open access: yesJACC Case Rep
Saito H   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy